Impact of Acute Rejection on Kidney Allograft Outcomes in Recipients on Rapid Steroid Withdrawal

Table 2

Immunosuppression management during the first posttransplant year.

	No rejection; (𝑛=375)	SR; (𝑛=46)	CR; (𝑛=36)	𝑃 value
	Trough tacrolimus level (mean ± SD in ng/dL)
1 month	10.7±2.9	10.1±2.8	10.9±4.1	.45
4 months	7.6±2.9	7.4±3.7	7.7±2.6	.89
12 months	7.8±3.9	7.6±3.0	7.0±3.2	.59
	Mycophenolate mofetil dose (mean ± SD in mg/day)
1 month	1673±412	1652±420	1607±540	.66
4 months	1392±478	1378±480	1383±486	.98
12 months	1261±476	1181±480	1223±468	.61
	% of patients on corticosteroids
12 months	9%**	10%*	55%^*,**	<.0001

SR: subclinical rejection, CR: clinical rejection, SD; standard deviation.
* 𝑃=.0002 for CR compared to SR group.
** 𝑃<.0001 for CR compared to No rejection group.